Effects of Selective Serotonin Reuptake Inhibitors and Venlafaxine During Pregnancy in Term and Preterm Neonates
- 1 January 2007
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 119 (1) , 52-59
- https://doi.org/10.1542/peds.2006-2133
Abstract
OBJECTIVES. Our goals were to (a) describe neonatal behavioral signs in a group of newborns exposed in utero to selective serotonin reuptake inhibitors or venlafaxine at the time of delivery, (b) compare the rate of neonatal behavioral signs, prematurity, and admission to specialized neonatal care between a group of exposed and unexposed newborns, and (c) compare the effects in exposed preterm and term newborns.Keywords
This publication has 40 references indexed in Scilit:
- Selective serotonin reuptake inhibitors and adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2006
- Antidepressant drugs during pregnancy and infant congenital heart defectReproductive Toxicology, 2006
- Exposition aux antidépresseurs inhibiteurs de la recapture de la sérotonine (IRS) en fin de grossesse : retentissement néonatalArchives de Pédiatrie, 2005
- The course of anxiety and depression through pregnancy and the postpartum in a community sampleJournal of Affective Disorders, 2004
- Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn NeurobehaviorPediatrics, 2004
- Placental Passage of Antidepressant MedicationsAmerican Journal of Psychiatry, 2003
- Outcomes of Prenatal Antidepressant ExposureAmerican Journal of Psychiatry, 2002
- Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitorsActa Paediatrica, 2001
- Neonatal paroxetine withdrawal syndromeArchives of Disease in Childhood: Fetal & Neonatal, 2001
- Effects of Third Trimester Fluoxetine Exposure on the NewbornJournal of Clinical Psychopharmacology, 1995